Trial Date: July 2018 (Ongoing)

Description: This trial is for patients aged 18 to 75 with moderate to severe atopic dermatitis. It involves administering oral medication and double-blind, randomized, placebo treatments controlled for 12 weeks and then an additional year of open-label extension.

Clinicaltrials.gov Identifier NCT03531957   IRB

Trial Date: October 2018 (Ongoing)

Description: This trial involves study medication versus active comparator. Participants include patients aged 18 and older with moderate to severe plaque psoriasis. It will be a 52-week multicenter, randomized, double-blind study.

Clinicaltrials.gov identifier NCT03624127   IRB

Trial Date: June 2018 (Ongoing)

Description: This trial encompasses comparing study drug versus active comparator. It will involve 44 weeks of treatment for patients aged 18 or older with moderate to severe chronic plaque psoriasis.

Clinicaltrials.gov identifier NCT03536884  

Trial Date: October 2018 (Ongoing)

Description: This trial is for patients with moderate to severe plaque psoriasis who weigh 90 kg (198 lb) or higher, who are 18 years of age of older. All patients will received the medication. The study is for 16 weeks with a long-term extension up to a year.

Clinicaltrials.gov Identifier NCT03504852   IRB

Trial Date: February 2019

Description: This trial is for patients with Basal Cell Carcinoma Nevus Syndrome (Gorlin Syndrome) who are 18 years of age or older. Patients will receive a topical gel to treat their face only for 14 months.

Clinicaltrials.gov Identifier NCT03703310   IRB